Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Vitoria

Showing results (21-30 of 91) with videos related to

Pageof 10
Sort By:
Journal of the International AIDS Society|April 16, 2020
Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID-19: initial assessmentNathan Ford, Marco Vitoria, Ajay Rangaraj, et al.
Bulletin of the World Health Organization|May 1, 2010
Implementation of co-trimoxazole prophylaxis and isoniazid preventive therapy for people living with HIVAnand A Date, Marco Vitoria, Reuben Granich, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 9, 2015
Comparative Safety and Neuropsychiatric Adverse Events Associated With Efavirenz Use in First-Line Antiretroviral Therapy: A Systematic Review and Meta-Analysis of Randomized TrialsNathan Ford, Zara Shubber, Anton Pozniak, et al.
AIDS (London, England)|July 19, 2006
National adult antiretroviral therapy guidelines in resource-limited countries: concordance with 2003 WHO guidelines?Eduard J Beck, Marco Vitoria, Sundhiya Mandalia, et al.
AIDS (London, England)|December 31, 2010
Effect on transmission of HIV-1 resistance of timing of implementation of viral load monitoring to determine switches from first to second-line antiretroviral regimens in resource-limited settingsAndrew N Phillips, Deenan Pillay, Geoff Garnett, et al.
Tropical Medicine & International Health : TM & IH|March 18, 2014
Systematic review and meta-analysis: Patient and programme impact of fixed-dose combination antiretroviral therapyRubeena Ramjan, Alexandra Calmy, Marco Vitoria, et al.
Plos One|November 19, 2013
Comparative efficacy of Lamivudine and emtricitabine: a systematic review and meta-analysis of randomized trialsNathan Ford, Zara Shubber, Andrew Hill, et al.
AIDS Research and Treatment|April 15, 2011
Utilization patterns and projected demand of antiretroviral drugs in low- and middle-income countriesFrançoise Renaud-Théry, Carlos Avila-Figueroa, John Stover, et al.
AIDS (London, England)|September 25, 2007
Use of antiretroviral therapy in resource-limited countries in 2006: distribution and uptake of first- and second-line regimensFrançoise Renaud-Théry, Boniface Dongmo Nguimfack, Marco Vitoria, et al.
AIDS (London, England)|January 26, 2018
The growing burden of noncommunicable disease among persons living with HIV in ZimbabweMikaela Smit, Jack Olney, Nathan P Ford, et al.
Pageof 10

Showing results (21-30 of 91) with videos related to

Sort By:
Pageof 10
Journal of the International AIDS Society|April 16, 2020
Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID-19: initial assessmentNathan Ford, Marco Vitoria, Ajay Rangaraj, et al.
Bulletin of the World Health Organization|May 1, 2010
Implementation of co-trimoxazole prophylaxis and isoniazid preventive therapy for people living with HIVAnand A Date, Marco Vitoria, Reuben Granich, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 9, 2015
Comparative Safety and Neuropsychiatric Adverse Events Associated With Efavirenz Use in First-Line Antiretroviral Therapy: A Systematic Review and Meta-Analysis of Randomized TrialsNathan Ford, Zara Shubber, Anton Pozniak, et al.
AIDS (London, England)|July 19, 2006
National adult antiretroviral therapy guidelines in resource-limited countries: concordance with 2003 WHO guidelines?Eduard J Beck, Marco Vitoria, Sundhiya Mandalia, et al.
AIDS (London, England)|December 31, 2010
Effect on transmission of HIV-1 resistance of timing of implementation of viral load monitoring to determine switches from first to second-line antiretroviral regimens in resource-limited settingsAndrew N Phillips, Deenan Pillay, Geoff Garnett, et al.
Tropical Medicine & International Health : TM & IH|March 18, 2014
Systematic review and meta-analysis: Patient and programme impact of fixed-dose combination antiretroviral therapyRubeena Ramjan, Alexandra Calmy, Marco Vitoria, et al.
Plos One|November 19, 2013
Comparative efficacy of Lamivudine and emtricitabine: a systematic review and meta-analysis of randomized trialsNathan Ford, Zara Shubber, Andrew Hill, et al.
AIDS Research and Treatment|April 15, 2011
Utilization patterns and projected demand of antiretroviral drugs in low- and middle-income countriesFrançoise Renaud-Théry, Carlos Avila-Figueroa, John Stover, et al.
AIDS (London, England)|September 25, 2007
Use of antiretroviral therapy in resource-limited countries in 2006: distribution and uptake of first- and second-line regimensFrançoise Renaud-Théry, Boniface Dongmo Nguimfack, Marco Vitoria, et al.
AIDS (London, England)|January 26, 2018
The growing burden of noncommunicable disease among persons living with HIV in ZimbabweMikaela Smit, Jack Olney, Nathan P Ford, et al.
Pageof 10